News
1d
MedPage Today on MSNIBD Biomarkers: Established Tests Are Helpful but Clinicians Want More"A diagnostic biomarker for IBD would be very impressive, but it would be even more impressive if we had a good biomarker ...
5d
MedPage Today on MSNDoublet Shows Activity in Rare, Aggressive Kidney CancerThe most common TRAEs of any grade were acneiform rash (93%), diarrhea (89%), proteinuria (78%), and dry skin (64%).
A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...
1d
GlobalData on MSNRoche and Genentech’s Lunsumio-Polivy shows promise in Phase III trialRoche and Genentech have announced outcomes from the randomised, multi-centre, international Phase III SUNMO trial for those ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today results from the Phase III SUNMO ...
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
Those adjustments just keep coming. As SFGATE reported, Genentech announced 436 layoffs in April 2024, and 93 more layoffs ...
Genentech is letting go of 143 employees who are based out of the company's headquarters in South San Francisco. | Genentech ...
After enduring multiple rounds of layoffs last year, Genentech’s employees are facing more uncertainty as the Roche unit lets ...
Other appointments to BIO's board for the 2025 through 2026 term include: Arcutis Bio's Frank Watanabe, named vice-chair; ...
7d
MedPage Today on MSNBTK Inhibitors for Multiple SclerosisMultiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...
Bottom line: Monday's calendar lines up two asymmetric biotech shots: If Sana's six-month data look anything like the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results